Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ)verified

XVIPF

Price:

$18.6

Market Cap:

$5.85B

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP....[Read more]

Industry

Medical - Devices

IPO Date

2014-07-21

Stock Exchange

OTC

Ticker

XVIPF

The PE Ratio as of December 2025 (TTM) for Xvivo Perfusion AB (publ) (XVIPF) is 186.00

According to Xvivo Perfusion AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is 186.00. This represents a change of -55.10% compared to the average of 414.27 of the last 4 quarters.

Xvivo Perfusion AB (publ) (XVIPF) Historical PE Ratio (quarterly & annually)

How has XVIPF PE Ratio performed in the past?

The mean historical PE Ratio of Xvivo Perfusion AB (publ) over the last ten years is 441.65. The current 186.00 PE Ratio has changed 4.11% with respect to the historical average. Over the past ten years (40 quarters), XVIPF's PE Ratio was at its highest in in the September 2018 quarter at 9.87K. The PE Ratio was at its lowest in in the March 2017 quarter at -11577.46.

Quarterly (TTM)
Annual

Average

441.65

Median

283.46

Minimum

-195.08

Maximum

1.32K

Xvivo Perfusion AB (publ) (XVIPF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Xvivo Perfusion AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 439.44%

Maximum Annual PE Ratio = 1.32K

Minimum Annual Increase = -605.16%

Minimum Annual PE Ratio = -195.08

Quarterly (TTM)
Annual
YearPE RatioChange
202489.46-16.72%
2023107.42-63.36%
2022293.22-70.25%
2021985.47-605.16%
2020-195.08-121.37%
2019912.77233.49%
2018273.70-28.20%
2017381.20-71.19%
20161.32K439.44%
2015245.2730.15%

Xvivo Perfusion AB (publ) (XVIPF) Average PE Ratio

How has XVIPF PE Ratio performed in the past?

The current PE Ratio of Xvivo Perfusion AB (publ) (XVIPF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

163.37

5-year avg

256.10

10-year avg

441.65

Xvivo Perfusion AB (publ) (XVIPF) PE Ratio vs. Peers

How is XVIPF’s PE Ratio compared to its peers?

Xvivo Perfusion AB (publ)’s PE Ratio is greater than PolyNovo Limited (63.00), greater than 4DMedical Limited (-31.67), greater than CellaVision AB (publ) (24.51), greater than Lattice Biologics Ltd. (-0.01), greater than Swedencare AB (publ) (92.35), greater than Viva Biotech Holdings (25.92), less than Avon Technologies Plc (239.05), greater than Beijing Tong Ren Tang Chinese Medicine Company Limited (14.72), greater than Nxera Pharma Co., Ltd. (-23.08), greater than Avisa Diagnostics Inc. (-0.23),

Build a custom stock screener for Xvivo Perfusion AB (publ) (XVIPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xvivo Perfusion AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xvivo Perfusion AB (publ) (XVIPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xvivo Perfusion AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Xvivo Perfusion AB (publ)'s PE Ratio?

How is the PE Ratio calculated for Xvivo Perfusion AB (publ) (XVIPF)?

What is the highest PE Ratio for Xvivo Perfusion AB (publ) (XVIPF)?

What is the 3-year average PE Ratio for Xvivo Perfusion AB (publ) (XVIPF)?

What is the 5-year average PE Ratio for Xvivo Perfusion AB (publ) (XVIPF)?

How does the current PE Ratio for Xvivo Perfusion AB (publ) (XVIPF) compare to its historical average?